Brought to you by 
Genzyme Biosurgery sells Snowden Pencer
24 Nov 2003
Executive Summary
Genzyme Biosurgery is selling its Snowden Pencer business of its Deknatel Snowden Pencer division to a corporation headed by Christopher Cashman, who was an executive in Genzyme's plastic surgery business.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Buy-out
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Genzyme Biosurgery sells Snowden Pencer
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice